Fortress Biotech, Inc.
USD18.74
+0.03 (+0.16%)
CEO
Lindsay A. Rosenwald
IPO Date
2017-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.68
Prev. Close
$18.71
Day Low
$18.68
Day High
$18.79
52W Low
$6.27
52W High
$21.43
Market Cap
$0.15B
Volume
0.01M
| 6,666 |
| $0.00 |
| 3 Jan 2024 | Lorenz Kevin | director | A-Award | Acquired | 3,333 | $0.00 |
| 3 Jan 2024 | ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | A-Award | Acquired | 216,465 | $0.00 |
| 3 Jan 2024 | Lu Lucy | director | A-Award | Acquired | 3,333 | $0.00 |
| 3 Jan 2024 | Rowinsky Eric K | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | A-Award | Acquired | 216,465 | $0.00 |
| 3 Jan 2024 | Harvey Jimmie | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | LOBELL J JAY | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | Hoenlein Malcolm | director | A-Award | Acquired | 3,333 | $0.00 |